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Effect of Ethanol on Vinyl Chloride
Carcinogenesis
by M. J. Radike,* K. L. Stemmer* and E. Bingham*
Four treatment groups (80 male Sprague-Dawley rats/group) were used in a 2 x 2 factorial
design: inhalation of 600 ppm vinyl chloride (VC) 4 hr/day, 5 days/week for 1 year; VC and
ingestion of 5% ethanol in water (v/v); filtered air and ethanol; filtered air. Ingestion ofethanol
was begun 4 weeks prior to inhalation ofVC and continued for life or termination ofthe study at
two and one-half years from the first VC exposure.
In this model system, ethanol potentiated the carcinogenic response to VC in the liver and
produced an excess of neoplasms in animals receiving ethanol alone. Inhalation of VC induced
angiosarcoma of the liver in 23% of the exposed animals; ethanol in addition to VC inhalation
increased the incidence to 50%. Concomitant administration ofVC and ethanol also produced an
excess of hepatocellular carcinoma and lymphosarcoma. Ethanol with or without VC had a
strong tumorigenic effect on the endocrine system. These results indicate that ethanol is a
cocarcinogen in relation to the carcinogen VC.
Introduction
The relationship between inhalation of vinyl
chloride (VC) and angiosarcoma ofthe liver is well
documented in man (1, 2) and animals (3, 4). Little
is known, however, of social or environmental
factors which may alterthe response ofmammalsto
the chronic inhalation of VC.
Short-term studies suggest that ethanol may
modify the potency of the carcinogen VC. The
uptake ofVC by rats in vivo was inhibited by prior
administration of ethanol (5), and in hepatocyte
suspensions ofrat liver, 4 mMethanol inhibited VC
metabolism 50% (6).
The following study was designed to elucidate
the effects ofchronic ethanol ingestion as a cofactor
in the carcinogenicity ofinhaled VC. The pathologi-
cal responses of rats to ethanol, ethanol with
concomitant inhalation of VC, inhalation of VC or
ifitered air, were examined in this model system.
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Materials and Methods
Three hundred and twenty Sprague-Dawley male
rats (Harlan Industries, Indianapolis) were divided
into four groups and exposed to toxic agents as
indicated in Table 1. Food and water were with-
drawn during VC inhalation and animals were held
in compartmented stainless-steel holding-cages which
were rotated in the chamber. Temperature in the
60 ft3 chamberranged from 70 to 75°F, air flow was
15 ft3/min and humidity
- 50%. The chamber
effluentwas mixed with naturalgas and incinerated
at 600-700°C; the incinerator effluent was cooled
and scrubbed of HCI with water.
VC (purity 99.9%, Matheson Gas Products) was
metered into filtered air prior to entering the
chamber. A Baseline Industries FID 1020 BTR gas
chromatograph equipped with a 10 port MPS 1610
multipoint samplermonitored VC concentrations in
the chamber and effluent; analysis time, 3 min.
All rats were autopsied, either at the time of
spontaneous death, when sacrificed because mori-
bund, or at the termination of the study two and
one-half years from the first exposure to VC.
Tissues were fixed inneutralformalin, embedded in
paraffin and cut at 6 ,um thickness. Sections were
59Table 1. Group designations and treatments.
Group Number of rats Diet Inhalation protocol
VC 80 Purina rat chow 600 ppma
VC-ethanol 80 +5% Ethanol in water (v/v)b 600 ppma
Ethanol 80c +5% Ethanol in water (v/v)b Filtered air
Filtered air 80 Purina rat chow Filtered air
a4 hr/day, 5 days/week, 1 year.
bAdministered 4 weeks prior to VC inhalation, ad libitum, for life.
cOne animal died by accident during experiment. Effective number, 79 rats.
stained with hematoxylin and eosin. Special stains
were used when necessary.
Results
Timed from the first exposure to VC, average
body weights of exposed animals were slowly
depressed. After 18 months the difference between
exposed and control rats was about 9%. There was
a more pronounced effect onthe survival ofexposed
animals. At 18 months, survival was 40% in VC
exposed and 18% in VC-ethanol exposed animals in
contrast to groups inhaling filtered air in which 70%
of the animals ingesting a normal diet and 73%
receiving 5% ethanol survived at 18 months. The
decreased survival in VC-exposed groups was due
to the development of pathological lesions induced
by VC or VC-ethanol rather than to nonspecific
causes such as murine pneumonia.
Angiosarcomas and hepatocellular carcinomas were
seen in the liver of rats inhaling VC (Table 2). In
some cases, more than one angiosarcoma or carci-
noma developed in an animal; the incidence re-
ported in Table 2 represents the type of lesion per
rat rather than the total number of liver lesions.
The first deaths from angiosarcoma occurred in a
VC-ethanol animal at 9 months and at 12 months in
a rat exposed to VC alone. The incidence of
angiosarcoma of the liver was increased from 23%
(VC alone) to 50% in VC-ethanol exposed rats.
Ethanol had a similar effect on the induction of
hepatocellular carcinoma by VC; 44% developed the
neoplasm from VC inhalation, and 60% developed
the carcinoma from treatment with both agents.
Angiosarcoma of the liver was not found in either
filtered air group; however, hepatocellular carci-
noma was observed in 10% ofthe ethanol-ingesting
and in 1% of untreated animals. The incidence of
"hyperplastic nodules" is included as an indicator of
toxicity.
Endocrine tumors, which comprised the second
largest group of neoplasms, are summarized in
Table 3. Malignant tumors included seminomas in
the ethanol group, a thyroid tumor in the VC-
ethanol group and adrenal tumors in the ethanol
and VC-ethanol groups. The incidence of pituitary
adenomas in untreated animals suggests that these
rats were unusually susceptible to this lesion. It
appeared that VC had no influence on the develop-
mentofpancreaticadenomas which consistedmostly
ofbeta cells. The total number ofendocrine tumors
in each group indicates a strong effect ofethanol on
the endocrine system.
The number ofneoplasms occurringat othersites
was small in comparison to those that developed in
liver and endocrine tissues (Table 4). Lymphosar-
comas were more frequent in VC-ethanol treated
rats although these tumors were found in all four
groups. Fibromas and fibrosarcomas occurred in
the region of mammary glands, but glandular
mammary tumors did not develop in the male
animals. The total number of fibrous tissue neo-
plasms (fibromas plus fibrosarcomas in the ethanol
group, 12 versus 5 and 6 in VC exposed animals)
may relate to the effect ofethanol on the endocrine
Table 2. Incidence of neoplasms in the liver per rat.a
Carcinoma Hyperplastic
Group Carcinoma Angiosarcoma and angiosarcoma nodules
VC 35 (11.5)b 18 (12) 6 (14) 26
VC-ethanol 48 (10) 40 (9) 10 (11) 22
Ethanol 8 (15) 0 0 29
Filtered air 1 0 0 10
aExposures: VC, 600 ppm, 4 hr/day, 5 days/wk, 1 year; 5% ethanol in water (v/v) for life.
bNumbers in parentheses denote month the first neoplasm was observed, timed from the first exposure to 600 ppm VC.
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Group Pituitary Thyroid Adrenal Pancreas Testes Total
VC 19 3 7 0 0 29
VC-ethanol 12 1 5 12 0 30
Ethanol 26 0 14 14 3 57
Filtered air 8 0 0 0 0 8
aExposure conditions and number of animals per group as reported in Table 1.
system. The number ofgliomas was small but may In groups exposed to VC alone, or ethanol alone,
be significant because ofthe rare occurrence ofthis the number of animals with tumors in each group
type ofneoplasm. Tumors at other sites were found was about equal (Table 5). There were, however,
in the kidney, epidermis, excretory pancreas and two major differences in the response ofrats to VC
parathyroid. or ethanol: distribution of tumors, and the number
The total incidence of neoplasms, malignant and of malignant versus benign neoplasms (Table 6).
nonmalignant, was highest in the VC-ethanol group The organ distribution varied markedly: VC expo-
expressed either as the number of animals per sure induced 59 hepatic and 29 endocrine neo-
group with one or more tumors or as the total plasms; ethanol induced 8 hepatic and 57 endocrine
number of tumors per group (Table 5). In animals neoplasms. Of the tumors linked to VC exposure
developing more than one tumor, frequent combi- alone, 77% were malignant. In animals ingesting
nations were endocrine and hepatic or multiple ethanol, a surprising 44% of the tumors were
hepatic tumors. malignant.
Table 4. Incidence of neoplasms in tissues other than liver and endocrine.a
Group Lymphosarcoma Fibroma Fibrosarcoma Glioma Other sites
VC 6 3 2 3 5
VC-ethanol 11 1 5 0 6
Ethanol 4 8 4 1 6
Filtered air 2 3 0 0 2
'Exposure conditions and number of animals per group as reported in Table 1.
Table 5. Incidence of all types of neoplasms.a
Number of rats Total number % of rats
Group Number of rats with tumor tumors with tumors
VC 80 63 107 78%
VC-ethanol 80 73 151 91%
Ethanol 79 61 91 77%
Filtered air 80 16 16 20%
aExposure conditions as reported in Table 1.
Table 6. Summary of malignant and benign tumors resulting from VC and ethanol.a
Group Malignant tumors Benign tumors Total number of tumors
VC 82 25 107
VC-ethanol 125 26 151
Ethanol 40 51 91
Filtered air 5 11 16
aExposure conditions and number of animals per group as reported in Table 1.
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In this animal model, ingested ethanol is a
cocarcinogen in relation to VC induction oftumors
in the liver. The incidence of angiosarcoma in
VC-ethanol dosed rats (50%) was more than double
that resulting from VC exposure alone (23%).
VC-ethanol also induced a greater number of
hepatocellular carcinomas (60%) than occurred in
VC-treated animals (44%). The first deaths from
angiosarcoma and carcinoma of the liver occurred
earlier in VC-ethanol dosed animals indicating a
shortened latent period.
The Sprague-Dawley rats used by Maltoni and
Lefemine in 1974 (4) were more resistant to the
effects of VC on the liver than the animals used in
this VC-ethanol study. Following a year-long expo-
sure to 500 ppm VC 4 hr/day, 5 days/week and
observation from first VC exposure for 135 weeks,
only 7 of 59 rats (12%) were reported to have
angiosarcoma in the liver (4). Angiosarcomas de-
veloped in other sites such as in subcutaneous
tissue, the abdominal cavity, neck, lungand uterus.
Hepatocellularcarcinomaswerenotreported. Zymbal
gland carcinomas were seen in 8% of Maltoni's VC
exposed animals; none were seen in this study.
Ethanol has been reported to potentiate the
toxicity of other halogenated hydrocarbons. In
whole animals, a variety of alcohols increased the
hepatotoxicity of carbon tetrachloride (CC14) when
ingested 16 to 18 hr prior to inhalation of CC14 (7).
Following acute exposures, CC14 toxicity was en-
hanced by ethanol as judged by the elevation of
serum glutamic-oxaloacetic transaminase levels. In
similar studies, trichloroethylene (TCE) or 1,1,1-
trichloroethane hepatotoxicity was potentiated by
ethanol, but only at high concentrations of inhaled
TCE or 1,1,1-trichloroethane (8).
Ethanol potentiation ofVC carcinogenesis in the
liveris probably due to an effect onVC metabolism.
Inhibition of VC uptake (5) and metabolism (6) by
ethanol suggests there is a shared step in the
oxidation of the two toxic agents. The most likely
candidates for competition are acetaldehyde and
chloroacetaldehyde. The normal substrate, acetal-
dehyde, would be oxidized preferentially resulting
in an increased half-life of chloroacetaldehyde.
Toxic manifestations of exposures were found
which were not related to the neoplastic response.
Many animals died because ofneoplasms or second-
ary changes caused by tumors; however, death
directly attributable to toxicity was not seen. The
toxicity of ethanol will be discussed in another
publication.
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